ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
Coherus BioSciences Inc

Coherus BioSciences Inc (CHRS)

0.8215
0.0402
(5.15%)
마감 20 11월 6:00AM
0.825
0.0035
(0.43%)
시간외 거래: 9:29AM

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

주요 통계 및 세부정보

가격
0.825
매수가
0.7904
매도가
0.825
거래량
2,136,064
0.75 일간 변동폭 0.8258
0.6603 52주 범위 3.70
market_cap
전일 종가
0.7813
개장가
0.78
최근 거래 시간
35
@
0.825
마지막 거래 시간
재정 규모
US$ 1,705,362
VWAP
0.798367
평균 볼륨(3m)
2,552,433
발행 주식
115,213,407
배당수익률
-
주가수익률
-0.40
주당순이익(EPS)
-2.06
매출
257.24M
순이익
-237.89M

Coherus BioSciences Inc 정보

Coherus BioSciences Inc is a commercial-stage biopharmaceutical company building an innovative immuno-oncology franchise funded with cash generated by its diversified portfolio of FDA-approved therapeutics. Toripalimab is being evaluated in pivotal clinical trials for the treatment of cancers of the... Coherus BioSciences Inc is a commercial-stage biopharmaceutical company building an innovative immuno-oncology franchise funded with cash generated by its diversified portfolio of FDA-approved therapeutics. Toripalimab is being evaluated in pivotal clinical trials for the treatment of cancers of the lung, breast, liver, skin, kidney, stomach, esophagus, and bladder. The company markets UDENYCA, a biosimilar of Neulasta in the United States, and expects to launch the FDA-approved Humira biosimilar YUSIMRY in the United States in 2023. The company is also developing CHS-305, a biosimilar of Avastin. The company generates revenue primarily from the United States. 더 보기

섹터
Biological Pds,ex Diagnstics
산업
Biological Pds,ex Diagnstics
웹사이트
본부
Wilmington, Delaware, USA
설립됨
-
Coherus BioSciences Inc is listed in the Biological Pds,ex Diagnstics sector of the 나스닥 with ticker CHRS. The last closing price for Coherus BioSciences was US$0.78. Over the last year, Coherus BioSciences shares have traded in a share price range of US$ 0.6603 to US$ 3.70.

Coherus BioSciences currently has 115,213,407 shares in issue. The market capitalisation of Coherus BioSciences is US$90.02 million. Coherus BioSciences has a price to earnings ratio (PE ratio) of -0.40.

CHRS 최신 뉴스

Coherus BioSciences Reports Third Quarter 2024 Financial Results and Provides Business Update

– Net revenue of $70.8 million in Q3 2024 driven by 30% increase in UDENYCA® net revenue, quarter-over-quarter – – UDENYCA labeling and packaging production resuming at third-party contract...

Coherus to Report Third Quarter 2024 Financial Results on November 6, 2024

REDWOOD CITY, Calif., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus,” NASDAQ: CHRS) today announced that its third quarter 2024 financial results will be released after...

Coherus BioSciences Reports Second Quarter 2024 Financial Results and Provides Business Update

– Net revenue of $65.0 million in Q2 2024 – – CHS-114 Phase 1 Study Recruitment Continues into Expansion Cohorts in Head and Neck Cancer in Combination with LOQTORZI – – Bryan McMichael...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
10.0455.769230769230.780.88550.728179060.78206783CS
4-0.0736-8.190518584460.89860.9550.660328080150.77140839CS
12-0.625-43.10344827591.451.490.660325524330.95021486CS
26-1.285-60.90047393362.112.170.660320930431.21208846CS
52-1.275-60.71428571432.13.70.660331343182.06224523CS
156-17.625-95.528455284618.45190.660322354644.32111572CS
260-18.275-95.680628272319.123.030.660317528257.38862643CS

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
PRFXPainReform Ltd
US$ 1.35
(152.34%)
194.42M
NCNCnoco noco Inc
US$ 0.1652
(70.31%)
759.98M
NXTTNext Technology Holding Inc
US$ 2.7699
(62.94%)
3.72M
SMCXDefiance Daily Target 2X Long SMCI ETF
US$ 41.475
(62.52%)
4.1M
TRNRInteractive Strength Inc
US$ 3.93
(55.34%)
25.25M
SLNSilence Therapeutics PLC
US$ 6.99
(-36.57%)
4.53M
AKTXAkari Therapeutics PLC
US$ 1.57
(-31.44%)
316.64k
QMMMQMMM Holdings Limited
US$ 1.25
(-27.75%)
4.54M
DMNDamon Inc
US$ 1.75
(-27.39%)
992.3k
GDHGGolden Heaven Group Holdings Ltd
US$ 1.50
(-26.47%)
316.77k
NCNCnoco noco Inc
US$ 0.1652
(70.31%)
759.98M
SYRSSyros Pharmaceuticals Inc
US$ 0.2718
(36.72%)
365.57M
WBUYWeBuy Global Ltd
US$ 0.1931
(21.37%)
251.45M
SMCISuper Micro Computer Inc
US$ 28.30
(31.38%)
229.22M
NVDANVIDIA Corporation
US$ 147.01
(4.89%)
225.41M

CHRS Discussion

게시물 보기
The GidDy uP Kid The GidDy uP Kid 2 주 전
https://schrts.co/sMeAHIGh

👍️0
The GidDy uP Kid The GidDy uP Kid 2 주 전
 daily psar fliPPed to the Bullish Buy Side…
👍️0
The GidDy uP Kid The GidDy uP Kid 2 주 전
76 after hours… 
👍️0
The GidDy uP Kid The GidDy uP Kid 2 주 전
 aDDing… 
👍️0
The GidDy uP Kid The GidDy uP Kid 2 주 전
 back to greeN… 
👍️0
The GidDy uP Kid The GidDy uP Kid 2 주 전
Nice daily Bullish Engulfing candle… 
https://schrts.co/TkiuQvJe
👍️0
The GidDy uP Kid The GidDy uP Kid 3 주 전
inverted HammeR off the lower Keltner line, with the daily psar flip to the Bullish side quickly approaching; furthermore, pinching in here on the pincher 🤏 …  
https://schrts.co/IJcPqwzg
👍️0
The GidDy uP Kid The GidDy uP Kid 3 주 전
...
👍️0
boytroy88 boytroy88 1 월 전
It's even lower now. ☹️
👍️0
Monksdream Monksdream 2 월 전
CHRS new 52 week low
👍️0
Monksdream Monksdream 4 월 전
CHRS under $2
👍️0
Monksdream Monksdream 4 월 전
CHRS under $2
👍️0
glenn1919 glenn1919 4 월 전
CHRS...................https://stockcharts.com/h-sc/ui?s=CHRS&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 7 월 전
CHRS under $3
👍️0
frans frans 9 월 전
short interest about 28.000.000 milj.up 7% today
👍️0
Mile High Marauder Mile High Marauder 9 월 전
Here is short interest link

https://www.nasdaq.com/market-activity/stocks/chrs/short-interest
👍️0
frans frans 9 월 전
you know how many shorts we have here to cover ????
my last buy was 2.08
👍️0
Mile High Marauder Mile High Marauder 9 월 전
I think selling these non core assets, with the probability of selling more has greatly diminished the need to raise money and has put some pressure on the shorts to cover some of this massive short. IMO
👍️ 1
frans frans 9 월 전
Coherus’ oncology assets include the UDENYCA® (pegfilgrastim-cbqv) franchise, with three FDA-approved presentations; LOQTORZI™ (toripalimab-tpzi), an FDA-approved, next-generation PD-1 inhibitor; and an immuno-oncology pipeline of next-generation tumor microenvironment oncology drug candidates.

Closing is anticipated in from jan 22
👍️0
Mile High Marauder Mile High Marauder 9 월 전
What fda news are u looking for?
👍️0
frans frans 9 월 전
up 14 % FDA news is coming
👍️0
frans frans 10 월 전
MM's we see an small cover now ? or company sell more ??,
👍️0
Mile High Marauder Mile High Marauder 10 월 전
27million share short. I wonder what the true valuation of the company is? I sure hope the shorts have to cover some day. I can’t say I’ve Seen a short this large on a listed stock. Implosion or explosion ,I guess only time will tell.
👍️0
moonurneighbor moonurneighbor 10 월 전
I think they are preparing for a sale
👍️0
Awl416 Awl416 10 월 전
Coherus Presents Positive Phase 2 Clinical Data on Casdozokitug, a First-in-Class IL-27-Targeted Antibody, at the 2024 ASCO GI Cancers Symposium
👍️0
frans frans 10 월 전
up from here now for the 1e FDA news
👍️0
frans frans 10 월 전
company dump big big here
👍️0
frans frans 10 월 전
have we an new company dump now ???????
👍️0
frans frans 10 월 전
now up from here and wait on FDA news (should be good)
👍️0
glenn1919 glenn1919 11 월 전
CHRS...........................https://stockcharts.com/h-sc/ui?s=CHRS&p=W&b=5&g=0&id=p86431144783
👍️0
tbonaces80 tbonaces80 11 월 전
Cup and handle formed
👍️0
tbonaces80 tbonaces80 11 월 전
We will test HOD. HH and HL’s
👍️0
Mile High Marauder Mile High Marauder 11 월 전
I find it hard to believe they’re going to dilute this company by 40% at this point Or at this price but you never know.
👍️0
Sierra20 Sierra20 11 월 전
Offering?
👍️0
eneels01 eneels01 11 월 전
Company needs to issue 40M shares at $2/sh. This would raise $80M, which would be enough to get through mid 2025…
👍️0
Mile High Marauder Mile High Marauder 12 월 전
21 million share short!! What is going on!
👍️0
Monksdream Monksdream 1 년 전
CHRS new 52 week low
👍️0
frans frans 1 년 전
about end dec.23 finish tests 400 peoples - FDA commercialization about june 24 if no problems
👍️0
eneels01 eneels01 1 년 전
Wow, instead of having a chance to go to $9, this stock has more of a chance to hit $1 by 2024. Oh well, I will just keep averaging down and sell when it eventually hits $5 again. Unfortunately that might not take place until 2025 or even 2026…
👍️0
frans frans 1 년 전
I selled and come back begin jan 24 after finish test 400 peoples about end dec. 23
👍️0
Mile High Marauder Mile High Marauder 1 년 전
Any idea who has this much stock to sell? I don’t see very many 5% holders.
👍️0
frans frans 1 년 전
what is going on here ??
👍️0
TimeFades TimeFades 1 년 전
Yup
👍️0
Monksdream Monksdream 1 년 전
For now
👍️0
TimeFades TimeFades 1 년 전
Looking strong
👍️0
Monksdream Monksdream 1 년 전
Few and far between in the biomed sector this year
👍️0
frans frans 1 년 전
slowly up from here
👍️0
Monksdream Monksdream 1 년 전
CHRS morning rally
👍️0
TimeFades TimeFades 1 년 전
Back in
👍️0
TimeFades TimeFades 1 년 전
Sold out first thing at 4 watching
👍️0

최근 히스토리

Delayed Upgrade Clock